左啡诺结构式
|
常用名 | 左啡诺 | 英文名 | tilidine hydrochloride hemihydrate |
|---|---|---|---|---|
| CAS号 | 27107-79-5 | 分子量 | 327.84600 | |
| 密度 | N/A | 沸点 | 354.2ºC at 760mmHg | |
| 分子式 | C17H26ClNO3 | 熔点 | 149-152?C | |
| MSDS | N/A | 闪点 | 114ºC | |
| 符号 |
GHS02, GHS06, GHS08 |
信号词 | Danger |
| 中文名 | 左啡诺 |
|---|---|
| 英文名 | tilidine hydrochloride hemihydrate |
| 中文别名 | 盐酸替利定 |
| 英文别名 | 更多 |
| 沸点 | 354.2ºC at 760mmHg |
|---|---|
| 熔点 | 149-152?C |
| 分子式 | C17H26ClNO3 |
| 分子量 | 327.84600 |
| 闪点 | 114ºC |
| 精确质量 | 327.16000 |
| PSA | 38.77000 |
| LogP | 3.50540 |
| InChIKey | NNMFVGNMUSEEEN-CKDKJTBNSA-N |
| SMILES | CCOC(=O)C1(c2ccccc2)CCC=CC1N(C)C.Cl.O |
| 储存条件 | -20°C Freezer |
| 水溶解性 | Freely soluble in water, very soluble in methylene chloride, freely soluble in ethanol (96 per cent). |
| 符号 |
GHS02, GHS06, GHS08 |
|---|---|
| 信号词 | Danger |
| 危害声明 | H225-H301 + H311 + H331-H370 |
| 警示性声明 | P210-P260-P280-P301 + P310-P311 |
| 危害码 (欧洲) | F,T |
| 风险声明 (欧洲) | 11-23/24/25-39/23/24/25 |
| 安全声明 (欧洲) | 7-16-36/37-45 |
| 危险品运输编码 | UN1230 - class 3 - PG 2 - Methanol, solution |
|
Development and validation of a sensitive UPLC-MS/MS method for the analysis of narcotic analgesics in urine and whole blood in forensic context.
Forensic Sci. Int. 215(1-3) , 136-45, (2012) Narcotic analgesics are widely (ab) used and sometimes only occur in low concentrations in biological samples. Therefore, a highly sensitive liquid chromatography tandem mass spectrometry method was d... |
|
|
An automated and fully validated LC-MS/MS procedure for the simultaneous determination of 11 opioids used in palliative care, with 5 of their metabolites.
J. Mass Spectrom. 41(5) , 633-40, (2006) A fully validated liquid chromatographic procedure coupled with electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) is presented for quantitative determination of the opioids buprenorphine... |
|
|
Pharmacokinetics of tilidine and naloxone in patients with severe hepatic impairment.
Arzneimittelforschung 57(2) , 106-11, (2007) The objective of the present study was to evaluate the pharmacokinetics of tilidine (CAS 20380-58-9), naloxone (CAS 465-65-6) and tilidine metabolites after administration of a single oral dose of a s... |
| Tilidin-HCl |
| valoronhydrochloride |
| DL-50 |
| go-1261 |
| D,L-ethyl-2-dimethylamino-1-phenyl-3-cyclohexen-carconacid-ethylester hydrochloride |
| w5759a |
| go1261c |
| valoron |
| tilidate |
| tilidine hydrochloride |